Article
PCSK9 inhibitor therapy in homozygous familial defective apolipoprotein B-100 due to APOB R3500Q: A case report.
Journal of clinical lipidology - 1 Jan 2000
Andersen Lars, Davis Tina, Testa Heidi, Andersen Rolf L
Abstract excerpt
Identification of a patient homozygous for familial defective apolipoprotein B-100(FDB) and successful treatment with PCSK9 inhibition.
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
